Oasis Diagnostics® Corporation
Oasis Diagnostics® Corporation was founded to conceive, develop and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on less-invasive specimens, such as saliva (oral fluid) whole blood or urine. The Company’s technologies address the three main segments of the In Vitro Diagnostics business molecular diagnostics, point-of-care testing and testing performed in the laboratory. The Company’s innovative saliva collection and testing portfolio may be applied in a variety of areas including drugs of abuse, infectious diseases (including HIV and tuberculosis), steroid hormones, oncology, immune response to anthrax and many others.
With early diagnosis being the key to disease prevention efforts on a global basis, Oasis Diagnostics® directs its research efforts to the development of rapid and laboratory based diagnostic products, which fit into a Corporate objective of improving the quality of healthcare for our global customers.
With particular emphasis on saliva diagnostics and salivary applications, Oasis Diagnostics® Corporation remains open to discussing new business opportunities with potential collaborative partners.
Oasis Diagnostics® Corporation is a global company targeting both domestic and international markets for its innovative saliva diagnostic portfolio. Our products can be found listed to your left.